MetLife Investment Management’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
Other funds holding DOX
MetLife Investment Management's DOX Position: Q2 2026 in Review
MetLife Investment Management reduced its Amdocs (DOX) stake by 0.92% in Q2 2026, selling an estimated $981 and leaving 1,725 shares worth $87.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.
MetLife Investment Management first reported a position in DOX in Q3 2018 and has held it in 21 quarters since. The position peaked at $236K in Q1 2023. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.
- MetLife Investment Management held 1,725 shares of Amdocs worth $87.2K as of Q2 2026.
- MetLife Investment Management sold 16 Amdocs shares in Q2 2026, an estimated $981.
- Amdocs made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2798 holding.
- MetLife Investment Management first reported a position in Amdocs in Q3 2018 and has held it in 21 quarters since.
- MetLife Investment Management's Amdocs position peaked at $236K in Q1 2023.
- 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.